Panacea Biotec

28/07/2025

24/07/2025

A New Era of Quality Begins!

We are thrilled to announce the successful launch of our electronic Quality Management System. This marks a giant leap forward in our digital transformation journey, bringing clarity, efficiency, and a paperless future to our quality systems.

23/07/2025

The Fight Against Dengue May Change Forever.

Panacea Biotec’s DengiAll - Live, attenuated chimeric recombinant tetravalent candidate vaccine has over 80% of non-structural epitopes covered in DengiAll.

An era with no more fear of mosquito bites. No more nets and repellants.

DengiAll - Designed for Excellence; Inspired by Nature

22/07/2025

We are proud to share a milestone that speaks to the heart of our mission. In just three years, Panacea Biotec has reached over 50 million newborns across low and middle income countries, a testament to our unwavering dedication to protecting the most vulnerable lives from the very first breath. This achievement is more than just a number. It represents millions of families empowered, healthcare systems strengthened, and communities given hope for a healthier future.

From expanding access to life-saving vaccines and essential medicines to building partnerships that prioritise maternal and child health, every step has been guided by our belief that healthcare is a universal right, not a privilege.

As we reflect on this milestone, we remain deeply committed to our vision of equitable access to healthcare for all.

21/07/2025

Many parents don’t realize that some kids' nutritional drinks contain caffeine - yes, the same stimulant found in coffee and energy drinks!
ChilRun full keeps it safe and clean with a 100% caffeine-free formula, made to support your child’s overall development - naturally.
🧠 Better focus
💪 Better growth
😴 Better sleep
All without the hidden buzz...
Caffeine isn’t for kids. But sadly, some drinks have it.
Choose better. Choose caffeine-free ChilRun full.

Visit www.7nshop.com to shop and switch to a cleaner, safer nutritional drink today.

18/07/2025

In our series, these videos offer a transparent and an unscripted view into our world. In this video, employees share their experience with 𝐂𝐑𝐌 𝐭𝐨𝐨𝐥 - '𝐍𝐢𝐤𝐡𝐚𝐚𝐫' developed in-house at Panacea Biotec. Play Now to know more.



https://panaceabiotec.darwinbox.in/ms/candidate/careers

17/07/2025

We are proud to share that Panacea Biotec has successfully delivered over 200 million doses of our world’s first fully-liquid innovative combination vaccines i.e. EasySix and EasyFive-TT across the globe.

𝐄𝐚𝐬𝐲𝐒𝐢𝐱 is a 6-in-1 fully-liquid wP-IPV based hexavalent vaccine offering protection against Diphtheria, Tetanus, Pertussis (whole-cell), Hepatitis B, Haemophilus influenzae type b (Hib), and Inactivated Polio. It has been accepted by WHO SAGE for the global immunisation program for over 130 countries and over 120 million children annually.

𝐄𝐚𝐬𝐲𝐅𝐢𝐯𝐞-𝐓𝐓 is a 5-in-1 fully-liquid wP-based pentavalent vaccine offering protection against Diphtheria, Tetanus, Pertussis (whole-cell), Hepatitis B and Haemophilus influenzae type b (Hib).

These vaccines are designed for expanded safety and efficacy in routine immunisation programs and together, they represent life-saving innovation, global partnerships, and a commitment to child health. A big thank you to our healthcare partners, frontline workers, and dedicated teams who made this impact possible!



World Health Organization (WHO) Gavi, the Vaccine Alliance

16/07/2025

We are proud to share that Panacea Biotec has delivered over 10 billion doses of polio vaccine to children across the globe. From India’s heartland to the most remote corners of the world, our vaccines have helped safeguard generations and brought humanity closer to the dream of eradicating polio from the world. Our contribution to polio eradication is not merely one of supply, it is a story of resilience, innovation, and deep-rooted public health commitment. It is a testament to India’s capability in shaping the future of global health, vaccine equity, and disease prevention.

A huge thank you to our partners: World Health Organization, Gavi, the Vaccine Alliance, Indian Red Cross Society -IRCS (National Headquarters, New Delhi India), Govt. of India, Biotechnology Industry Research Assistance Council (BIRAC), UNICEF, Gates Foundation, Global Polio Eradication Program, CDL Kasauli, Bio Farma - Indonesia and countless frontline heroes who made this journey possible.

11/07/2025

In our series, these videos offer a transparent and an unscripted view into our world.

In this video, employees share their experience with the 𝐈𝐧𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐠𝐫𝐚𝐦 - '𝐏𝐫𝐚𝐯𝐞𝐬𝐡' at Panacea Biotec. Play Now to know more.

08/07/2025

In our series, these videos offer a transparent and an unscripted view into our world.

In this video, employees share about 𝐖𝐨𝐫𝐤 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 𝐚𝐭 𝐏𝐚𝐧𝐚𝐜𝐞𝐚 𝐁𝐢𝐨𝐭𝐞𝐜. Play Now to know more.

07/07/2025

The Fight Against Dengue May Change Forever.

Panacea Biotec’s DengiAll - Live, attenuated chimeric recombinant tetravalent candidate vaccine, has completed Phase I/II studies with more than 94% of participants showing robust and balanced immune response.

An era with no more fear of mosquito bites. No more nets and repellants.

DengiAll - Designed for Excellence; Inspired by Nature!



https://pubmed.ncbi.nlm.nih.gov/35252836/